RFX2 promotes tumor cell stemness through epigenetic regulation of PAF1 in spinal ependymoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RFX2 promotes tumor cell stemness through epigenetic regulation of PAF1 in spinal ependymoma

Published:2023-12 Issue:3 Volume:165 Page:487-497
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Zhang Zhe,Chen Yusheng,Guo Yang,Shen Hanwei,Wang Jiangtao,Chen Hang

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-023-04506-0.pdf

Reference33 articles.

1. Neumann JE, Spohn M, Obrecht D et al (2020) Molecular characterization of histopathological ependymoma variants. Acta Neuropathol 139(2):305–318. https://doi.org/10.1007/s00401-019-02090-0

2. Celano E, Salehani A, Malcolm JG et al (2016) Spinal cord ependymoma: a review of the literature and case series of ten patients. J Neurooncol 128(3):377–386. https://doi.org/10.1007/s11060-016-2135-8

3. Zhang Q, Cheng S, Wang Y et al (2021) Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated macrophages. Nat Commun 12(1):6867. https://doi.org/10.1038/s41467-021-27018-9

4. Servidei T, Meco D, Martini M et al (2021) The BET inhibitor OTX015 exhibits in vitro and in vivo antitumor activity in pediatric ependymoma stem cell models. Int J Mol Sci 22(4):1877. https://doi.org/10.3390/ijms22041877

5. Mack SC, Pajtler KW, Chavez L et al (2018) Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Nature 553(7686):101–105. https://doi.org/10.1038/nature25169

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-cancer investigation of RFX family and associated genes identifies RFX8 as a therapeutic target in leukemia;Heliyon;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3